From EV Acceleration to SaaS Breakouts: Wall Street’s Thursday Focus

September 4, 2025

DENVER, Colo., Sep 04, 2025 (247marketnews.com)- Wall Street opened today with a blend of strong earnings momentum, strategic insider buys, and bold SaaS pivots, here’s your essential pre-market breakdown:

Polestar (NASDAQ:PSNY) charged into the spotlight after reporting 56.5% revenue growth for H1 2025, hitting $1.42 billion on the back of 51% retail sales growth. CEO Michael Lohscheller credited the brand’s “relentless focus” on cost control and a growing retail footprint. Despite a hefty non-cash impairment dragging margins, the company achieved a positive adjusted gross margin of 1.4%, a marked turnaround.

Other key metrics:

  • $719 million in cash on hand
  • $200 million in new equity raised
  • Polestar 5 to debut at IAA in September
  • Production confirmed in Europe for the upcoming Polestar 7, launching in 2028

TEN Holdings (NASDAQ:XHLD) continues to gain traction as it prepares to launch Ten Pro, its SaaS platform aimed at maintaining broadcast-grade quality while simplifying delivery for enterprise clients. According to All-Star analyst Barry M. Sine, CFA, CMT, who initiated coverage pre-IPO, with an $8 price target, TEN’s dual growth strategy, organic SaaS expansion and post-IPO M&A, could create a “high-margin, scalable growth engine.”

Highlights:

  • Ten Pro SaaS beta launched in July
  • Targeting 90% gross margins on SaaS
  • Global integration with Japan’s V-Cube (TSE: 3681), majority owner
  • Strategic sales and marketing overhaul underway
  • Potential ecosystem merger post-IPO

Sine maintains his $8/share price target, emphasizing the “compelling valuation” and operational alignment toward profitability.

Shares of Biodesix (NASDAQ:BDSX) are climbing pre-market after filings revealed a $1.5 million insider purchase by biotech investor Jack W. Schuler, signaling strong insider confidence in the lung cancer diagnostics firm. Schuler’s buy appears to be a vote of confidence as Biodesix scales its multi-test platform and commercial reach.

WATCHLIST SPOTLIGHT: Tickers Gaining Buzz

Purple Biotech (NASDAQ:PPBT) continues to explore its lead oncology asset in combination therapies. Expect movement with any clinical update or trial data release.

Neo-Concept International (NASDAQ:NCI) appears to be popping with the holiday retail season approaching.

Concorde International Group (NASDAQ:CIGL) secured SG$11.6M (~US$9M) in multi-year contracts through May, already exceeding 2024 totals. Strong recurring revenue trend

Zeta Global Holdings (NYSE:ZETA) earnings growth nudged up and it cleared a technical buy point

Please go to https://247marketnews.com/ten-holdings-event-solutions/ for additional 247marketnews.com XHLD disclosure

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (PSNY, XHLD, BDSX, ZETA, NCI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.